Heart Monitor Cuts Deaths After Fainting
A trial shows wearing a small heart monitor for 14 days after an ER visit for unexplained fainting more than doubles detection of dangerous arrhythmias and
Fitting a wearable heart monitor for 14 days after an emergency room visit for unexplained fainting more than doubles the detection of dangerous heart rhythm problems. The strategy also nearly halved the death rate after one year, according to trial results presented at the European Society of Cardiology Congress in Munich and published in the New England Journal of Medicine.
Professor Matthew Reed, who led the study, stated the findings provide strong evidence the approach can save lives. The research was funded by the British Heart Foundation and involved 2,234 people across 45 UK emergency departments.
How the Two-Week Monitor Works
Unexplained fainting sends roughly 650,000 people to UK emergency rooms each year. While often harmless, it can signal a dangerous arrhythmia. These are notoriously hard to catch because a patient's heart rhythm has usually returned to normal by the time they reach the hospital.
Current standard care involves referral to an outpatient clinic for monitoring, which can take from six weeks to two years after the ER visit. A typical Holter monitor is worn for only 48 hours. The new monitor is about the size of a car key fob. It is worn continuously on the chest for a full 14 days, even in the shower, and data is transmitted to clinicians afterward.
In the trial, half the patients received this two-week monitor within 72 hours of their ER visit. The other half received standard care. The results showed a dramatic improvement in identifying life-threatening conditions like complete heart block or ventricular tachycardia.
| Metric | Two-Week Monitor Group | Standard Care Group |
|---|---|---|
| Arrhythmias detected after one year | 22% | 9% |
| Average time to identify an arrhythmia | 22 days | 54.5 days |
| Death rate after one year | 1.5% | 2.9% |
| Patients given antiarrhythmic medication | 10.8% | 7.3% |
| Patients receiving a pacemaker | 6.8% | 4.6% |
Impact on Treatment and Daily Life
The faster detection led directly to more people starting treatment. If the monitor picked up a serious arrhythmia, the patient's clinician was alerted within 24 working hours. Professor Bryan Williams of the British Heart Foundation said the trial shows how simple new technology can identify treatable disturbances in heart rhythm to reduce risk.
There was no significant difference in the average number of fainting episodes patients reported after one year between the two groups. The monitor group averaged 1.37 episodes, while the standard care group averaged 1.58. The critical difference was in diagnosis and intervention.
Researchers hope the strategy will become standard NHS practice. Professor Reed emphasized that continuous data for two weeks is invaluable for cardiologists trying to diagnose an elusive arrhythmia. It allows treatment to be sped up significantly.
One Patient's Experience
Stephen, a 68-year-old from West Lothian with a history of atrial fibrillation, joined the trial after fainting twice in a week. Standard hospital checks found no immediate cause. He wore the monitor for 14 days without further fainting episodes.
However, the device data revealed his atrial fibrillation was not controlled. His heart rate was hitting 227 beats per minute at times. This dangerous finding, which would have been missed, led clinicians to increase his dosage of bisoprolol medication. Stephen described the monitor as user-friendly and unobtrusive during daily activities.
